Jean-Baptise obtained his Master’s degree in Cellular and Molecular Biology at Paris-Sorbonne University in 2018 after a six-month internship with us. He focused on the development of a human microbiota model in collaboration with the Pharmacology Lab of University of Rennes 1 (INSERM U1230).

He will keep on working on this subject as a PhD student, and has joined us to develop a new in vitro skin microbiota model for the phenotypic screening of molecules. This model will include skin commensal bacteria such asS.epidermidis and will be used to study the impact of skin microbiota on wound healing, UV radiation, inflammatory response and oxidative stress.

In relation to this topic, a recent short paper (Stacy et Belkaid 2019. Science 363, 227-228) has shown that skin microbiota can promote skin repair, immunity and antimicrobial defense. Furthermore, this article contains a summary of the multifaceted roles of S. epidermidis in skin physiology.

Source: Microbial guardians of skin health

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

Microbiota companies unite to push for EU regulation reform | HCS Pharma · May 31, 2019 at 2:23 pm

[…] Of course, we are heavily working in the field, with a focus on skin with the reconstruction of a 3D “in vitro” skin model with BIOMIMESYS® in a HCS […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.